"Picolinamide derivatives as kinase inhibitors"

Details for Australian Patent Application No. 2012200132 (hide)

Owner Novartis AG

Inventors Burger, Matthew T.; Han, Wooseok; Lan, Jiong; Nishiguchi, Gisele

Agent Davies Collison Cave

Pub. Number AU-A-2012200132

Parent 2009289319

Filing date 10 January 2012

Wipo publication date 2 February 2012

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/444 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

2 February 2012 Application Open to Public Inspection

  Published as AU-A-2012200132

2 February 2012 Complete Application Filed

6 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012200133-Mutant receptors and their use in a nuclear receptor-based inducible gene expression system

2012200131-Apparatus for pipeline inspection